These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 9846359)

  • 41. Measurement and interpretation of Salmonella typhi Vi IgG antibodies for the assessment of adaptive immunity.
    Parker AR; Bradley C; Harding S; Sánchez-Ramón S; Jolles S; Kiani-Alikhan S
    J Immunol Methods; 2018 Aug; 459():1-10. PubMed ID: 29800575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Vaccines against typhoid fever.
    Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
    Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Field effectiveness of Vi polysaccharide typhoid vaccine in the People's Republic of China.
    Arya SC
    J Infect Dis; 2002 Mar; 185(6):845; author reply 845-6. PubMed ID: 11920305
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunization against typhoid: a short review.
    Bhatia RS; Sibia SS
    J Assoc Physicians India; 1994 May; 42(5):424. PubMed ID: 7829448
    [No Abstract]   [Full Text] [Related]  

  • 45. Safety and immunogenicity of Salmonella typhi Ty21a vaccine in young Thai children.
    Cryz SJ; Vanprapar N; Thisyakorn U; Olanratmanee T; Losonsky G; Levine MM; Chearskul S
    Infect Immun; 1993 Mar; 61(3):1149-51. PubMed ID: 8432597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Animal and human studies on oral vaccination against typhoid and paratyphoid fever (author's transl)].
    Meshalova AN; Kurlova VI; Yanisker GY; Lavrovskaya VM; Blant ME; Negina YP
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):167-71. PubMed ID: 4216250
    [No Abstract]   [Full Text] [Related]  

  • 47. [The role of H-antigen in postvaccinal immunity against typhoid and paratyphoid].
    Kheĭfets LB; Stanislavskiĭ ES; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1974; 00(5):113-4. PubMed ID: 4218035
    [No Abstract]   [Full Text] [Related]  

  • 48. Diversity of Salmonella Typhi-responsive CD4 and CD8 T cells before and after Ty21a typhoid vaccination in children and adults.
    Rudolph ME; McArthur MA; Magder LS; Barnes RS; Chen WH; Sztein MB
    Int Immunol; 2019 Apr; 31(5):315-333. PubMed ID: 30951606
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Immunochemical examination of typhoid and paratyphoid vaccines prepared from envelope and O antigens (author's transl)].
    Hatunceva NV; Mironova MV; Ryapolova RG
    Acta Microbiol Acad Sci Hung; 1974; 21(1-2):135-41. PubMed ID: 4216248
    [No Abstract]   [Full Text] [Related]  

  • 50. Towards a marketplace for Vi polysaccharide-conjugate typhoid vaccines.
    Gibani MM
    Lancet Infect Dis; 2022 Apr; 22(4):435-436. PubMed ID: 34942089
    [No Abstract]   [Full Text] [Related]  

  • 51. Oral typhoid vaccine Ty21a.
    Sutton RG; Merson MH
    Lancet; 1983 Mar; 1(8323):523. PubMed ID: 6131224
    [No Abstract]   [Full Text] [Related]  

  • 52. Typhoid immunisation.
    Ghai OP; Paul VK
    Indian J Pediatr; 1984; 51(408):71-6. PubMed ID: 6378786
    [No Abstract]   [Full Text] [Related]  

  • 53. Should close contacts of returning travellers with typhoid fever be protected by vaccination?
    Kantele A
    Vaccine; 2015 Mar; 33(12):1419-21. PubMed ID: 25678244
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Advances in vaccines for typhoid fever.
    Gupta A; Jalla S; Sazawal S; Bhan MK
    Indian J Pediatr; 1994; 61(4):321-39. PubMed ID: 8002060
    [No Abstract]   [Full Text] [Related]  

  • 55. Evaluation of two WHO First International Standards for Vi polysaccharide from Citrobacter freundii and Salmonella enterica subspecies enterica serovar Typhi.
    Gao F; Swann C; Rigsby P; Rijpkema S; Lockyer K; Logan A; Bolgiano B;
    Biologicals; 2019 Jan; 57():34-45. PubMed ID: 30502020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Typhoid conjugate vaccines: a new tool in the fight against antimicrobial resistance.
    Andrews JR; Baker S; Marks F; Alsan M; Garrett D; Gellin BG; Saha SK; Qamar FN; Yousafzai MT; Bogoch II; Antillon M; Pitzer VE; Kim JH; John J; Gauld J; Mogasale V; Ryan ET; Luby SP; Lo NC
    Lancet Infect Dis; 2019 Jan; 19(1):e26-e30. PubMed ID: 30170987
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A cluster-randomized effectiveness trial of Vi typhoid vaccine in India.
    Sur D; Ochiai RL; Bhattacharya SK; Ganguly NK; Ali M; Manna B; Dutta S; Donner A; Kanungo S; Park JK; Puri MK; Kim DR; Dutta D; Bhaduri B; Acosta CJ; Clemens JD
    N Engl J Med; 2009 Jul; 361(4):335-44. PubMed ID: 19625715
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Immunologic efficacy of typhoid alcoholic vaccine enriched with Vi-antigen in opisthorchiasis].
    Baranova NA; Peklo GN; Razmashkina AP
    Zh Mikrobiol Epidemiol Immunobiol; 1972 Nov; 49(11):66-9. PubMed ID: 4645855
    [No Abstract]   [Full Text] [Related]  

  • 59. Enteric Fever and Invasive Nontyphoidal Salmonellosis--9th International Conference on Typhoid and Invasive NTS Disease, Bali, Indonesia, April 30-May 3, 2015.
    Khan MI; Katrinak C; Freeman A; Franco-Paredes C
    Emerg Infect Dis; 2016 Apr; 22(4):. PubMed ID: 27366797
    [No Abstract]   [Full Text] [Related]  

  • 60. Live oral typhoid vaccine Salmonella Typhi Ty21a - a surrogate vaccine against non-typhoid salmonella?
    Kantele A; Pakkanen SH; Siitonen A; Karttunen R; Kantele JM
    Vaccine; 2012 Nov; 30(50):7238-45. PubMed ID: 23084770
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.